Vaniqa
This article was originally published in The Rose Sheet
Executive Summary
Second round of national TV ads launching now and print ads debuting in April focus on educating women who remove unwanted facial hair rather than building brand awareness as the first campaign did, Bristol Myers Squibb said during Feb. 22 press event. Co-marketed by Gillette, Rx topical cream (13.9% eflornithine) debuted in September (1"The Rose Sheet" Aug. 7, 2000, p. 6). Second round of ads will feature close-up shots of women applying the cream and an illustration of how product effects the hair follicle